DK1429802T3 - Tilførselssystem for biologisk komponent - Google Patents

Tilførselssystem for biologisk komponent

Info

Publication number
DK1429802T3
DK1429802T3 DK02766451.5T DK02766451T DK1429802T3 DK 1429802 T3 DK1429802 T3 DK 1429802T3 DK 02766451 T DK02766451 T DK 02766451T DK 1429802 T3 DK1429802 T3 DK 1429802T3
Authority
DK
Denmark
Prior art keywords
supply system
component supply
biological component
biological
supply
Prior art date
Application number
DK02766451.5T
Other languages
English (en)
Inventor
Tanya Borek
Catherine Federici
Michael P Hite
Christopher London
Stephen J Turner
Original Assignee
Tntgamble Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tntgamble Inc filed Critical Tntgamble Inc
Application granted granted Critical
Publication of DK1429802T3 publication Critical patent/DK1429802T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK02766451.5T 2001-09-28 2002-09-30 Tilførselssystem for biologisk komponent DK1429802T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32593701P 2001-09-28 2001-09-28
PCT/US2002/031309 WO2003026687A1 (en) 2001-09-28 2002-09-30 Delivery system for biological component

Publications (1)

Publication Number Publication Date
DK1429802T3 true DK1429802T3 (da) 2013-02-18

Family

ID=23270074

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02766451.5T DK1429802T3 (da) 2001-09-28 2002-09-30 Tilførselssystem for biologisk komponent

Country Status (12)

Country Link
US (2) US8007777B2 (da)
EP (1) EP1429802B1 (da)
JP (1) JP5041651B2 (da)
KR (1) KR100979877B1 (da)
CN (1) CN100478026C (da)
AU (1) AU2002330187B2 (da)
CA (2) CA2778208C (da)
DK (1) DK1429802T3 (da)
ES (1) ES2398910T3 (da)
PT (1) PT1429802E (da)
RU (1) RU2313355C2 (da)
WO (1) WO2003026687A1 (da)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070098784A1 (en) * 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
ITMI20022344A1 (it) * 2002-11-05 2004-05-06 Biofarm Srl Prodotto in pellicola a rapida dissoluzione in acqua, per il trattamento del latte con batteri e/o enzimi.
US8871266B2 (en) * 2003-10-01 2014-10-28 Commonwealth Scientific & Industrial Research Organisation Probiotic storage and delivery
AU2004275438B2 (en) * 2003-10-01 2008-05-29 Commonwealth Scientific & Industrial Research Organisation Probiotic storage and delivery
WO2005060937A1 (en) * 2003-12-23 2005-07-07 Chr. Hansen A/S Compressed tablets comprising viable probiotic microorganisms
GB0330009D0 (en) 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations
EP1720579A1 (de) * 2004-02-17 2006-11-15 Wheli Inter AG Galaktomannane und/oder glucomannane zur erhöhung von wirkstoff-bioverfügbarkeit
EP1729742A1 (en) * 2004-03-31 2006-12-13 BPSI Holdings, Inc. Enteric coatings for orally ingestible substrates
CA2605162A1 (en) * 2005-04-15 2006-10-26 North Carolina State University Methods and compositions to modulate adhesion and stress tolerance in bacteria
US20060252830A1 (en) * 2005-05-06 2006-11-09 Brandon Stephen F Method for the treatment of magnesium and potassium deficiencies
US20060252831A1 (en) * 2005-05-06 2006-11-09 Christopher Offen Method for the treatment of magnesium and potassium deficiencies
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
JP5100634B2 (ja) * 2006-03-24 2012-12-19 興和株式会社 口腔内速崩壊性錠剤
WO2008002058A1 (en) * 2006-06-26 2008-01-03 B.M.Tech World Co., Ltd. Method of preparing powder kimchi and kimchi composition using the same
ITMI20062286A1 (it) * 2006-11-28 2008-05-29 Anidral Srl Una composizione per la somministrazione di principi biologicamente attivi in ambito ginecologico e rettale nonche' i suoi usi
ITMI20070452A1 (it) * 2007-03-07 2008-09-08 Anidral Srl Compressa comprendente microrganismi ed una combinazione di eccipienti e relativo procedimento di produzione
TW200904340A (en) * 2007-05-11 2009-02-01 Mannatech Inc Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same
US20100272859A1 (en) * 2007-08-28 2010-10-28 Pepsico, Inc. Delivery and controlled release of encapsulated water-insoluble flavorants
US9186640B2 (en) * 2007-08-28 2015-11-17 Pepsico, Inc. Delivery and controlled release of encapsulated lipophilic nutrients
US20100055180A1 (en) * 2007-10-10 2010-03-04 Mallinckrodt Baker, Inc. Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
AU2008311289A1 (en) * 2007-10-10 2009-04-16 Avantor Performance Materials, Inc. Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2163239A1 (de) * 2008-05-27 2010-03-17 Qiagen GmbH Produkte, die Biopartikel enthalten, Verfahren zu ihrer Herstellung
CN102170791B (zh) * 2008-08-04 2015-09-09 帝斯曼知识产权资产管理有限公司 包含益生菌复合物的珠粒的制备
JP2012500643A (ja) * 2008-08-28 2012-01-12 セーホーエル．ハンセン アクティーゼルスカブ 細菌組成物
FR2938405B1 (fr) * 2008-11-20 2011-04-22 Florane Complement alimentaire et procede de distribution d'un tel complement
MX336355B (es) 2009-03-04 2016-01-14 Orexo Ab Formulacion resistente al abuso.
CA2761000C (en) 2009-05-08 2018-05-29 Orexo Ab Composition for sustained drug delivery comprising geopolymeric binder
US20110123677A1 (en) * 2009-11-25 2011-05-26 Pepsico, Inc. High acid beverage products and methods to extend probiotic stability
NO2613784T3 (da) 2010-09-07 2018-05-12
WO2012035561A2 (en) * 2010-09-17 2012-03-22 Lovely Professional University Improved oral targetted drug delivery system
US9265842B2 (en) 2010-10-15 2016-02-23 Cornell University Compositions and methods for treating endocrine, gastrointestinal or autoimmune disorders
ITMI20131578A1 (it) * 2013-09-25 2015-03-26 Giellepi S P A Sostanza e formulazione per il trattamento delle malattie infiammatorie croniche intestinali
US10624934B2 (en) 2014-03-06 2020-04-21 Research Institute At Nationwide Children's Hospital Prebiotic formulations
AU2015227075A1 (en) * 2014-03-06 2016-09-22 Ohio State Innovation Foundation Probiotic formulations and methods for use
FR3018193B1 (fr) * 2014-03-10 2017-09-08 Probionov Comprime vaginal muco-adhesif a liberation prolongee
US20170028183A1 (en) * 2014-04-08 2017-02-02 Mayo Foundation For Medical Education And Research Ingestible capsule
AU2015284425B2 (en) 2014-07-01 2021-04-01 Probi USA, Inc. Bi-layer dual release probiotic tablets
TWI788111B (zh) 2015-01-02 2022-12-21 美商梅拉洛伊卡公司 多元補充品組成物
TWI790189B (zh) 2015-01-02 2023-01-21 美商梅拉洛伊卡公司 細菌組成物
WO2016109853A2 (en) 2015-01-02 2016-07-07 Melaleuca, Inc. Dietary supplement compositions
JP7283216B2 (ja) * 2018-05-17 2023-05-30 大正製薬株式会社 経口組成物
EP3806877A1 (en) 2018-06-18 2021-04-21 Probi Ab Probiotic compositions and uses thereof
WO2019242839A1 (en) 2018-06-18 2019-12-26 Probi Ab Lactobacillus plantarum compositions and uses thereof
WO2020086487A1 (en) 2018-10-22 2020-04-30 Research Institute At Nationwide Children's Hospital Compositions and methods for preventing and treating antibiotic induced pathologies using probiotics in the biofilm state
JP7499704B2 (ja) * 2019-01-30 2024-06-14 三菱商事ライフサイエンス株式会社 保存安定性と、耐胃液分解安定性を付与したプロバイオティクス組成物
GB201905386D0 (en) 2019-04-16 2019-05-29 Probi Ab Probiotic compositions and uses thereof
WO2020247536A1 (en) 2019-06-03 2020-12-10 Research Institute At Nationwide Children's Hospital Prebiotic formulations for prevention of sepsis and necroenterocolitis induced neurodevelopmental deficiencies
GB201908154D0 (en) 2019-06-07 2019-07-24 Probi Ab Lactobacillus compositions and uses thereof
GB201908706D0 (en) 2019-06-18 2019-07-31 Probi Ab Lactobacillus compositions and uses thereof
US11737987B2 (en) 2019-12-17 2023-08-29 9286-3620 Quebec Inc. Oral delivery systems based on in situ forming protein/polysaccharide coacervates
JP6944036B1 (ja) * 2020-11-05 2021-10-06 株式会社ファンケル ハードカプセル製剤
JP2023019150A (ja) * 2021-07-28 2023-02-09 株式会社ファンケル ハードカプセル製剤、粉末組成物
WO2026017258A1 (en) 2024-07-18 2026-01-22 Probi Ab Lacticaseibacillus compositions and uses thereof

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB825480A (en) * 1957-07-13 1959-12-16 Johann Carl Pflueger Improvements in or relating to ingestible dry micro-organism preparations and method for producing the same
US4264573A (en) 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4542020A (en) 1984-08-17 1985-09-17 E. R. Squibb & Sons, Inc. Long-lasting adhesive antifungal suppositories
DE3681348D1 (de) 1985-06-11 1991-10-17 Teijin Ltd Oral-arzneizubereitung mit retardwirkung.
US4755180A (en) 1986-06-16 1988-07-05 Alza Corporation Dosage form comprising solubility regulating member
US4806368A (en) * 1987-09-16 1989-02-21 Reddy Malireddy S Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation
IE60311B1 (en) 1987-09-24 1994-06-29 American Home Prod Sustained release etodolac
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
GB8926639D0 (en) * 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations
US5194172A (en) 1990-09-13 1993-03-16 The Procter & Gamble Company Aerated and freezer bar soap compositions containing sucrose as a mildness aid and a processing aid
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
US5288507A (en) * 1992-07-29 1994-02-22 Merck & Co., Inc. Ibuprofen antacid combinations
US5419917A (en) 1994-02-14 1995-05-30 Andrx Pharmaceuticals, Inc. Controlled release hydrogel formulation
US6241983B1 (en) * 1994-10-28 2001-06-05 Metagenics, Inc. Bacteria-and fiber-containing composition for human gastrointestinal health
US5531681A (en) * 1995-01-13 1996-07-02 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding
US5830884A (en) * 1995-01-18 1998-11-03 National Starch And Chemical Investment Holding Corporation Pharmaceutical products containing thermally-inhibited starches
JP2859216B2 (ja) * 1995-08-10 1999-02-17 日清製粉株式会社 耐酸性に優れた腸内有用細菌含有顆粒の製造方法
SI0814782T1 (en) * 1995-12-22 2003-04-30 Kowa Company, Ltd. Pharmaceutical composition stabilized with a basic agent
US6274171B1 (en) 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
EP0813866A3 (en) * 1996-06-17 1999-01-20 Eisai Co., Ltd. Therapeutic agent for joint diseases
US5830503A (en) 1996-06-21 1998-11-03 Andrx Pharmaceuticals, Inc. Enteric coated diltiazem once-a-day formulation
RU2118535C1 (ru) * 1997-03-20 1998-09-10 Институт клинической и экспериментальной лимфологии СО РАМН Комплексный бактериальный препарат
WO1998042289A1 (en) 1997-03-21 1998-10-01 Kimberly-Clark Worldwide, Inc. Dual-zoned absorbent webs
IL123984A (en) 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
MY129120A (en) 1997-08-19 2007-03-30 Global Palm Products Sdn Bhd Process for the production of monoglyceride based on the glycerolysis of methyl ester
KR100387245B1 (ko) * 1997-10-17 2003-08-19 일양약품주식회사 유산균의안정화를위한미세장용성코팅과립
US6337091B1 (en) 1997-10-27 2002-01-08 Temple University - Of The Commonwealth System Of Higher Education Matrix for controlled delivery of highly soluble pharmaceutical agents
US6090411A (en) * 1998-03-09 2000-07-18 Temple University Monolithic tablet for controlled drug release
US7201923B1 (en) 1998-03-23 2007-04-10 General Mills, Inc. Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
SE9801287D0 (sv) * 1998-04-14 1998-04-14 Astra Ab Incorporation of active substances in carrier matrixes
KR20000011247A (ko) * 1998-07-23 2000-02-25 김윤 다당류를이용한대장선택성약물전달조성물및약학제제
US7498310B1 (en) 1998-08-13 2009-03-03 Beiersdorf Ag Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin of age marks and/or for preventing tanning of the skin, in particular tanning of the skin caused by UV radiation
AU1543400A (en) * 1998-12-11 2000-07-03 Urex Biotech Inc. Oral administration of lactobacillus for the treatment and prevention of urogenital infection
EP1072258A1 (de) * 1999-07-28 2001-01-31 Greither, Peter Eine Kapsel für die Freisetzung von Bakterien, enthaltend ein Bakterienlyophilisat und ein Verfahren zu ihrer Herstellung
US6375994B1 (en) 1999-08-20 2002-04-23 Sun Ten Laboratories, Inc. Preparation of fiber, L-glutamine and a soy derivative for the purpose of enhancement of isoflavone bioavailability
US6936275B2 (en) 1999-12-20 2005-08-30 Scolr, Inc. Amino acid modulated extended release dosage form
WO2003024427A1 (en) 1999-12-20 2003-03-27 Temple University Of The Commonwealth System Of Higher Education Tableted oral extended release dosage form
US6716449B2 (en) 2000-02-08 2004-04-06 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
US6458384B2 (en) * 2000-02-23 2002-10-01 Impetus Ag Pharmaceutical with predetermined activity profile
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
NL1018100C2 (nl) 2001-05-18 2002-11-19 Stork Titan Bv Inrichtingen voor het bereiden van stroombaar beslag en doseereenheid.
WO2003004009A1 (en) 2001-07-02 2003-01-16 Geneva Pharmaceuticals, Inc. Pharmaceutical composition
US7122370B2 (en) 2003-01-14 2006-10-17 Randolph Stanley Porubcan Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life

Also Published As

Publication number Publication date
US8007777B2 (en) 2011-08-30
US20030096002A1 (en) 2003-05-22
WO2003026687A1 (en) 2003-04-03
RU2004110617A (ru) 2005-03-10
KR100979877B1 (ko) 2010-09-02
RU2313355C2 (ru) 2007-12-27
EP1429802A4 (en) 2007-11-07
HK1066969A1 (en) 2005-03-18
ES2398910T3 (es) 2013-03-22
CA2778208C (en) 2015-11-10
CA2461708A1 (en) 2003-04-03
CA2461708C (en) 2012-08-07
CN100478026C (zh) 2009-04-15
PT1429802E (pt) 2013-01-24
JP5041651B2 (ja) 2012-10-03
JP2005528324A (ja) 2005-09-22
US20050152966A1 (en) 2005-07-14
EP1429802B1 (en) 2012-11-07
AU2002330187B2 (en) 2008-01-03
KR20040045027A (ko) 2004-05-31
EP1429802A1 (en) 2004-06-23
CN1596124A (zh) 2005-03-16
CA2778208A1 (en) 2003-04-03

Similar Documents

Publication Publication Date Title
DK1429802T3 (da) Tilførselssystem for biologisk komponent
DE60226091D1 (de) Kraftstoffversorgungssystem
DE60236186D1 (de) Stentanbringungssystem
DE60128730D1 (de) Elektromagnetisch-gekoppelte verbindungssystemarchitektur
DE60216027D1 (de) Ortungssystem
DE60212066D1 (de) Abgabespritze
DE60224608D1 (de) Drucksystem
NO20034154L (no) Posisjoneringssystem
DE10390346D2 (de) Mikrofluidik-System
DK1372771T3 (da) Injektionsordning
DE60227963D1 (de) Behandlungssystem
FI20010429L (fi) Punnitusjärjestelmä
DE60233109D1 (de) Radidentifikator- ortungsverfahren
DE60214042D1 (de) Nass-trocken-reinigungssystem
DE50211902D1 (de) Systemteil
DE60231432D1 (de) Steuersystem
FI20011896A0 (fi) Tuloilmalaite
EP1384028A4 (en) Integrated illumination system
EP1445063A4 (en) pallet holder
DE60223613D1 (de) Mehrprozessorsystem
DE60226793D1 (de) Drucksystem
DE50115676D1 (de) Heizungsanlage
DE50212923D1 (de) Feuchtmittel-Zufuhrsystem
DE50115802D1 (de) Dafür
DE60220721D1 (de) Eduktor-mischersystem